AffiliationAnu Research Centre, Department of Obstetrics & Gynaecology, University College, Cork, Cork University Maternity Hospital, Wilton, Cork, Ireland., email@example.com
*Disease Models, Animal
MetadataShow full item record
CitationPlacenta. 2011 Jun;32(6):413-9. Epub 2011 Apr 17.
AbstractPreeclampsia remains a leading cause of maternal and fetal morbidity and mortality and has an unknown etiology. The limited progress made regarding new treatments to reduce the incidence and severity of preeclampsia has been attributed to the difficulties faced in the development of suitable animal models for the mechanistic research of this disease. In addition, animal models need hypotheses on which to be based and the slow development of testable hypotheses has also contributed to this poor progress. The past decade has seen significant advances in our understanding of preeclampsia and the development of viable reproducible animal models has contributed significantly to these advances. Although many of these models have features of preeclampsia, they are still poor overall models of the human disease and limited due to lack of reproducibility and because they do not include the complete spectrum of pathophysiological changes associated with preeclampsia. This review aims to provide a succinct and comprehensive assessment of current animal models of preeclampsia, their uses and limitations with particular attention paid to the best validated and most comprehensive models, in addition to those models which have been utilized to investigate potential therapeutic interventions for the treatment or prevention of preeclampsia.
- Role of aldosterone availability in preeclampsia.
- Authors: Escher G, Mohaupt M
- Issue date: 2007 Apr
- The global impact of pre-eclampsia and eclampsia.
- Authors: Duley L
- Issue date: 2009 Jun
- Preeclampsia: progress and puzzle.
- Authors: Fadigan AB, Sealy DP, Schneider EF
- Issue date: 1994 Mar
- [Pathophysiology of preeclampsia].
- Authors: Schmidt M, Kimmig R
- Issue date: 2007
- Preeclampsia. Part 1: clinical and pathophysiologic considerations.
- Authors: Pridjian G, Puschett JB
- Issue date: 2002 Sep